Cyclophosphamide NDC 14335-470

NDC codes

FDA NDC Directory

Product NDC (as listed)14335-470Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14335-0470Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
14335-470-10	14335047010	1 VIAL, SINGLE-DOSE in 1 CARTON (14335-470-10) / 25 mL in 1 VIAL, SINGLE-DOSE (14335-470-01)Marketed from Jan 3, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cyclophosphamide
Generic name (nonproprietary): cyclophosphamide for injection
Active ingredients: Cyclophosphamide — 500 mg/25mL
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Hainan Poly Pharm. Co., Ltd.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218632
Marketing start: Jan 3, 2025
Listing expires: Dec 31, 2026
Identifiers: Product ID 14335-470_2aca7731-9fcc-4625-e063-6394a90a6020SPL ID 2aca7731-9fcc-4625-e063-6394a90a6020SPL set ID 6fde2705-a2d8-4d48-9618-b9d99d051373RxCUI 1734917, 1734919, 1734921UNII 8N3DW7272PUPC 0314335472013, 0314335470019, 0314335471016

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N414335047010 followed by a unit qualifier and the quantity

Package 14335-0470-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 218632

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218632
Product	Strength	Form · route	Labeler	Product NDC
Cyclophosphamidecyclophosphamide for injection	Cyclophosphamide 500 mg/25mL	Injection, Powder, For solutionIntravenous	Slate Run Pharmaceuticals, LLC	70436-105
Cyclophosphamidecyclophosphamide for injection	Cyclophosphamide 1 g/50mL	Injection, Powder, For solutionIntravenous	Slate Run Pharmaceuticals, LLC	70436-106
Cyclophosphamidecyclophosphamide for injection	Cyclophosphamide 2 g/100mL	Injection, Powder, For solutionIntravenous	Slate Run Pharmaceuticals, LLC	70436-107
Cyclophosphamidecyclophosphamide for injection	Cyclophosphamide 1 g/50mL	Injection, Powder, For solutionIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-471
Cyclophosphamidecyclophosphamide for injection	Cyclophosphamide 2 g/100mL	Injection, Powder, For solutionIntravenous	Hainan Poly Pharm. Co., Ltd.	14335-472

Cyclophosphamide (cyclophosphamide for injection) NDC 14335-470